Guts & Glory: Both of Cynata’s iPSC Trials Flop, GVH Phase 2 and KOA Phase 3
Sad day for the industry, here's a summary of the CEO/Executive Chairman's readouts of the trials.
ElpasBio Completes Patient Enrollment in Phase III Trial of AlloJoin for Knee Osteoarthritis
This marks the first stem cell therapy for KOA to reach Phase III in China. The race is heating up...
Cord for Life Completes Dosing of First Clinical Trial Using Cord Blood Stem Cells for Lower Back Pain
The Phase 1 cord blood-derived stem cell therapy for sacroiliac joint-related lower back pain showed an encouraging early safety profile and symptom improvement, supporting plans to begin Phase 2 later this year.
Gallant Reports Positive Pilot Data for Feline Osteoarthritis Stem Cell Therapy; Receives FDA Eligibility for Expanded Conditional Approval Pathway
Gallant said its pilot study found that intravenous stem cell therapy significantly improved pain and quality of life in cats with osteoarthritis versus placebo, supporting a faster regulatory route as the company pursues a disease-modifying treatment for an underserved condition.
BioRestorative reports Good Preliminary Data for FDA-Fast-Tracked Stem Cell Therapy for Disc Disease
BioRestorative's early Phase 2 trial results show notable improvements in function and pain for chronic lumbar disc disease patients, moving one step closer to a BLA.
New trial: Umbilical-derived stem cells for knee cartilage
This small German biotech company is joining the knee OA stem cell race.
New Study: Extracellular Vesicles in Fibrin Gel for Cartilage Repair (Italy)
The Italian researchers will do a 51 person trial with MSC-derived EVs in PRP-derived fibrin gels.
Korean Company Launches iPSCs Osteoarthritis Trial
Biotech company YiPSCELL breaks ground on a new trial, will head to safety & efficacy trials soon.